SCHEMBL209364

SCHEMBL209364

O=C(O)c1ccc(-c2ccc(CC3CCN(C4CCCCC4)C3=O)c(OC(F)(F)F)c2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 1/20 0.46
GCGR P47871 3/20 0.41
GIPR P48546 1/20 0.41
SSTR5 P35346 2/20 0.39
PDE4B Q07343 6/20 0.39
PDE4A P27815 4/20 0.39
PDE4C Q08493 4/20 0.39
PDE4D Q08499 4/20 0.39
MAP4K4 O95819 1/20 0.36
DNMT3A Q9Y6K1 1/20 0.35
HSD17B13 Q7Z5P4 1/20 0.34
NR1H4 Q96RI1 1/20 0.34
IDH1 O75874 1/20 0.34
RXRA P19793 1/20 0.34
RXRB P28702 1/20 0.34
RXRG P48443 1/20 0.34
RARA P10276 1/20 0.34
RARB P10826 1/20 0.34
RARG P13631 1/20 0.34
EPHX2 P34913 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL209391 0.90 HSD11B1 (0.41) HSD11B1GCGRGIPRPDE4BPDE4A
SCHEMBL14391256 0.87 HSD11B1 (0.39) HSD11B1
SCHEMBL209250 0.87 EPHX2 (0.40) HSD11B1EPHX2
SCHEMBL208203 0.87 EPHX2 (0.40) HSD11B1PDE4BPDE4DEPHX2
SCHEMBL209411 0.87 HSD11B1 (0.39) HSD11B1
SCHEMBL209360 0.86 HSD11B1 (0.38) HSD11B1PDE4BPDE4D
SCHEMBL208261 0.86 HSD11B1 (0.38) HSD11B1SSTR5PDE4BPDE4D
SCHEMBL208290 0.85 HSD11B1 (0.38) HSD11B1PDE4BPDE4D
SCHEMBL208314 0.85 HSD11B1 (0.38) HSD11B1EPHX2
SCHEMBL209346 0.85 HSD11B1 (0.48) HSD11B1GCGRGIPRSSTR5PDE4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2016047-B1 BIPHENYL AMIDE LACTAM DERIVATIVES AS INHIBITORS OF 11- BETA-HYDROXYSTEROID DEHYDROGENASE 1 LILLY CO ELI (US) 2013-08-28 EP disclosed
US-8088776-B2 Biphenyl amide lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 ELI LILLY AND COMPANY (US) 2012-01-03 US disclosed
US-20090156571-A1 BIPHENYL AMIDE LACTAM DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 ELI LILLY AND COMPANY 2009-06-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090156571-A1 BIPHENYL AMIDE LACTAM DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 HSD11B1, HSD17B1, HSD11B2 HSD11B1 1/4885GCGR 320/4885GIPR 562/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.